Have a personal or library account? Click to login

Reference interval and upper decission limit for serum uric acid – an evidence-based approach on Romanian population using an a posteriori method

Open Access
|May 2019

References

  1. 1. Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19(5):640-53. DOI: 10.1093/oxfordjournals.molbev.a00412310.1093/oxfordjournals.molbev.a00412311961098
  2. 2. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol. 2005;25(1):3-8. DOI: 10.1016/j.semnephrol.2004.09.00210.1016/j.semnephrol.2004.09.00215660328
  3. 3. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):240410. DOI: 10.1001/jama.283.18.240410.1001/jama.283.18.240410815083
  4. 4. Alvarez-Lario B, Macarron-Vicente J. Uric acid and evolution. Rheumatology (Oxford). 2010;49(11):20105. DOI: 10.1093/rheumatology/keq20410.1093/rheumatology/keq20420627967
  5. 5. Hershfield MS, Roberts LJ, 2nd, Ganson NJ, Kelly SJ, Santisteban I, Scarlett E, et al. Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci U S A. 2010;107(32):143516. DOI: 10.1073/pnas.100107210710.1073/pnas.1001072107292253820660758
  6. 6. Mironczuk-Chodakowska I, Witkowska AM, Zujko ME. Endogenous non-enzymatic antioxidants in the human body. Adv Med Sci. 2018;63(1):68-78. DOI: 10.1016/j.advms.2017.05.00510.1016/j.advms.2017.05.00528822266
  7. 7. Ziberna L, Martelanc M, Franko M, Passamonti S. Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial Cells. Sci Rep. 2016;6:29240. DOI: 10.1038/srep2924010.1038/srep29240493390527381978
  8. 8. Xu X, Li C, Zhou P, Jiang T. Uric acid transporters hiding in the intestine. Pharm Biol. 2016;54(12):3151-5. DOI: 10.1080/13880209.2016.119584710.1080/13880209.2016.119584727563755
  9. 9. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8-14. DOI: 10.1016/j.ijcard.2015.08.10910.1016/j.ijcard.2015.08.10926316329
  10. 10. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005;52(1):283-9. DOI: 10.1002/art.2076110.1002/art.2076115641075
  11. 11. Zhang H, Li Y, Mao Z, Liu X, Zhang X, Yang K, et al. Sex-specific associations of serum uric acid with metabolic syndrome in Chinese rural population: The RuralDiab study. Clin Chim Acta. 2018;480:119-25. DOI: 10.1016/j.cca.2018.02.00310.1016/j.cca.2018.02.003
  12. 12. Jin YL, Zhu T, Xu L, Zhang WS, Liu B, Jiang CQ, et al. Uric acid levels, even in the normal range, are associated with increased cardiovascular risk: the Guangzhou Biobank Cohort Study. Int J Cardiol. 2013;168(3):2238-41. DOI: 10.1016/j.ijcard.2013.01.21410.1016/j.ijcard.2013.01.214
  13. 13. Wannamethee SG, Papacosta O, Lennon L, Whincup PH. Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study. Int J Cardiol. 2018;252:18792. DOI: 10.1016/j.ijcard.2017.11.08310.1016/j.ijcard.2017.11.083
  14. 14. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, et al. Serum uric acid and brain ischemia in normal elderly adults. Neurology. 2007;69(14):1418-23. DOI: 10.1212/01.wnl.0000277468.10236.f110.1212/01.wnl.0000277468.10236.f1
  15. 15. Chen Q, Yin YJ, Chen WY, Wu JN, Huang X. Assessment of the association between serum uric acid levels and the incidence of hypertension in nonmetabolic syndrome subjects: A prospective observational study. Medicine (Baltimore). 2018;97(6):e9765. DOI: 10.1097/MD.000000000000976510.1097/MD.0000000000009765
  16. 16. Shani M, Vinker S, Dinour D, Leiba M, Twig G, Holtzman EJ, et al. High Normal Uric Acid Levels Are Associated with an Increased Risk of Diabetes in Lean, Normoglycemic Healthy Women. J Clin Endocrinol Metab. 2016;101(10):3772-8. DOI: 10.1210/jc.2016-210710.1210/jc.2016-2107
  17. 17. Kamei K, Konta T, Hirayama A, Suzuki K, Ichikawa K, Fujimoto S, et al. A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population. Nephrol Dial Transplant. 2014;29(12):2286-92. DOI: 10.1093/ndt/gfu25610.1093/ndt/gfu256
  18. 18. Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, et al. Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci. 2014;18(9):1295-306.
  19. 19. Bardin T. Hyperuricemia starts at 360 micromoles (6 mg/dL). Joint Bone Spine. 2015;82(3):141-3. DOI: 10.1016/j.jbspin.2015.01.00210.1016/j.jbspin.2015.01.002
  20. 20. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(9491):1059-62. DOI: 10.1016/S01406736(05)67402-810.1016/S01406736(05)67402-8
  21. 21. Hoffmann RG. Statistics in the Practice of Medicine. JAMA. 1963;185:864-73. DOI: 10.1001/jama.1963.0306011006802010.1001/jama.1963.0306011006802014043090
  22. 22. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol. 2010;133(2):1806. DOI: 10.1309/AJCPN5BMTSF1CDYP10.1309/AJCPN5BMTSF1CDYP20093226
  23. 23. Totan M, Gligor FG, Bojita M, Grigore C, Grigore C. Determining hemoglobin reference values in children and teenagers from Sibiu area. Rev Romana Med Lab. 2013;21(1):39-45.10.2478/rrlm-2013-0016
  24. 24. Antonescu E, Szakacs J, Totan M. Determination of reference intervals for total calcium and magnesium specific for children and adolescents in Sibiu area. Rev Romana Med Lab. 2016;24(3):347-50. DOI: 10.1515/rrlm-2016-003010.1515/rrlm-2016-0030
  25. 25. Das M, Borah NC, Ghose M, Choudhury N. Reference Ranges for Serum Uric Acid among Healthy Assamese People. Biochem Res Int. 2014;2014:171053. DOI: 10.1155/2014/17105310.1155/2014/171053394219324672726
  26. 26. Yang Y, Jiang H, Tang A, Xiang Z. Reference intervals for serum bilirubin, urea, and uric acid in healthy Chinese geriatric population. J Clin Lab Anal. 2017.10.1002/jcla.22318681723328922477
  27. 27. Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis. 2013;72(5):694-700. DOI: 10.1136/annrheumdis-2011-20125410.1136/annrheumdis-2011-20125422736095
  28. 28. Dorobantu M, Tautu OF, Buzas R, Lighezan D. Serum uric acid in primary hypertension: cause or consequence? – Data from SEPHAR II Survey. Hypertonia és Nephrologia. 2014;18(3-4):89-96.
  29. 29. Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):18691. DOI: 10.1097/BOR.000000000000002810.1097/BOR.000000000000002824419750
  30. 30. Chen JH, Yeh WT, Chuang SY, Wu YY, Pan WH. Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol. 2012;31(2):239-45. DOI: 10.1007/s10067-011-1802-610.1007/s10067-011-1802-621761146
  31. 31. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136-41. DOI: 10.1002/art.3052010.1002/art.3052021800283
  32. 32. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895-900. DOI: 10.1002/art.178020032010.1002/art.1780200320856219
  33. 33. Meshkani R, Zargari M, Larijani B. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetol. 2011;48(1):79-88. DOI: 10.1007/s00592-010-0231-310.1007/s00592-010-0231-321046418
  34. 34. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15(2):189-92. DOI: 10.1002/art.178015020910.1002/art.17801502095027604
  35. 35. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29-42. DOI: 10.1136/annrheumdis-2016-20970710.1136/annrheumdis-2016-20970727457514
  36. 36. Alem MM. Allopurinol and Endothelial function: A Systematic Review with Meta-Analysis of Randomized Controlled Trials. Cardiovasc Ther. 2018:e12432. DOI: 10.1111/1755-5922.1243210.1111/1755-5922.12432617506729673103
  37. 37. Deng G, Qiu Z, Li D, Fang Y, Zhang S. Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials. Med Sci Monit. 2016;22:1389-97. DOI: 10.12659/MSM.89837010.12659/MSM.898370
  38. 38. Agarwal V, Hans N, Messerli FH. Effect of allopurinol on blood pressure: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2013;15(6):435-42. DOI: 10.1111/j.1751-7176.2012.00701.x10.1111/j.1751-7176.2012.00701.x803380923730993
  39. 39. Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis JP, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376. DOI: 10.1136/bmj.j237610.1136/bmj.j2376546147628592419
  40. 40. Odden MC, Amadu AR, Smit E, Lo L, Peralta CA. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002. Am J Kidney Dis. 2014;64(4):550-7. DOI: 10.1053/j.ajkd.2014.04.02410.1053/j.ajkd.2014.04.024417730024906981
  41. 41. Kang E, Hwang SS, Kim DK, Oh KH, Joo KW, Kim YS, et al. Sex-specific Relationship of Serum Uric Acid with All-cause Mortality in Adults with Normal Kidney Function: An Observational Study. J Rheumatol. 2017;44(3):380-7. DOI: 10.3899/jrheum.16079210.3899/jrheum.16079228089980
  42. 42. Zalawadiya SK, Veeranna V, Mallikethi-Reddy S, Bavishi C, Lunagaria A, Kottam A, et al. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III. Eur J Prev Cardiol. 2015;22(4):513-8. DOI: 10.1177/204748731351934610.1177/204748731351934624431384
  43. 43. Castro VMF, Melo AC, Belo VS, Chaves VE. Effect of allopurinol and uric acid normalization on serum lipids hyperuricemic subjects: A systematic review with meta-analysis. Clin Biochem. 2017;50(18):1289-97. DOI: 10.1016/j.clinbiochem.2017.07.01310.1016/j.clinbiochem.2017.07.01328754333
  44. 44. Derosa G, Maffioli P, Reiner Z, Simental-Mendia LE, Sahebkar A. Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis. Drugs. 2016;76(9):947-56. DOI: 10.1007/s40265-016-0591-210.1007/s40265-016-0591-227260336
  45. 45. Desideri G, Virdis A, Casiglia E, Borghi C, Working Group on Uric A, Cardiovascular Risk of the Italian Society of H. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study. High Blood Press Cardiovasc Prev. 2018. DOI: 10.1007/s40292-018-0250-710.1007/s40292-018-0250-729427170
DOI: https://doi.org/10.2478/rrlm-2019-0019 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 147 - 158
Submitted on: Dec 17, 2018
Accepted on: Mar 3, 2019
Published on: May 2, 2019
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2019 Catalin Codreanu, Horatiu Popoviciu, Elena Rezus, Corina Delia Mogosan, Ioannis Gardikiotis, Claudiu Costinel Popescu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.